The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1


Ozeren M., Karahan S. C. , Ozgur M., Eminagaoglu S., Unsal M. A. , Baytan S., ...More

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, vol.84, no.10, pp.987-991, 2005 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 84 Issue: 10
  • Publication Date: 2005
  • Doi Number: 10.1111/j.0001-6349.2005.00817.x
  • Journal Name: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.987-991

Abstract

Background. Markers of fibrinolysis, thrombin-activatable fibrinolysis inhibitor (TAFI), tissue-type plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1) levels were studied for the evaluation of short-term effects of raloxifene administration in postmenopausal women.